Decreased autonomic modulation of heart rate and altered cardiac sympathovagal balance in patients with Cushing's syndrome: Role of endogenous hypercortisolism

Neuroendocrinology

Volumn 97, Issue 4, 2013, Pages 309-317

  Chandran, Dinu S ^a   Ali, Naseer ^a   Jaryal, Ashok Kumar ^a   Jyotsna, Viveka P ^a   Deepak, Kishore Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cardiac autonomic functions; Cushing's syndrome; Endogenous hypercortisolism; Heart rate variability; High frequency power; Sympathovagal balance

Indexed keywords

GLUCOSE; HYDROCORTISONE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ELECTROCARDIOGRAM; ENDOGENOUS CUSHING SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPERTENSION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; ALTERED CARDIAC SYMPATHOVAGAL BALANCE; ENDOGENOUS HYPERCORTISOLISM; HEART DISEASE; RR INTERVAL; YOUNG ADULT;

ADOLESCENT; ADULT; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; CHILD; CUSHING SYNDROME; FEMALE; HEART; HEART DISEASES; HEART RATE; HUMANS; HYDROCORTISONE; MALE; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 84879171103     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000345905     Document Type: Article

References (32)

1. Etxabe J, Vazquez JA: Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin Endocrinol (Oxf) 1994; 40: 479-484
2. Steffensen C, Bak AM, Rubeck KZ, Jørgensen JO: Epidemiology of Cushing's syndrome. Neuroendocrinology 2010; 92(suppl 1):1-5
3. De Leo M, Pivonello R, Auriemma RS, Cozzolino A, Vitale P, Simeoli C, et al: Cardiovascular disease in Cushing's syndrome: Heart versus vasculature. Neuroendocrinology 2010; 92(suppl 1):50-54
4. Pivonello R, Faggiano A, Lombardi G, Colao A: The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 2005; 34: 327-339, viii
5. Cicala MV, Mantero F: Hypertension in Cushing's syndrome: From pathogenesis to treatment. Neuroendocrinology 2010; 92(suppl 1):44-49
6. Trementino L, Arnaldi G, Appolloni G, Daidone V, Si C, Casonato A, et al: Coagulopathy in Cushing's syndrome. Neuroendocrinology 2010; 92(suppl 1):55-59
7. Valassi E, Biller BM, Klibanski A, Misra M: Adipokines and cardiovascular risk in Cushing's syndrome. Neuroendocrinology 2012; 95: 187-206
8. Jyotsna VP, Naseer A, Sreenivas V, Gupta N, Deepak KK: Effect of Cushing's syndrome - endogenous hypercortisolemia on cardiovascular autonomic functions. Auton Neurosci 2011; 160: 99-102
9. Fallo F, Maffei P, Dalla Pozza A, Carli M, Della Mea P, Lupia M, et al: Cardiovascular autonomic function in Cushing's syndrome. J Endocrinol Invest 2009; 32: 41-45
10. Takahashi H, Takeda K, Ashizawa H, Inoue A, Yoneda S, Yoshimura M, et al: Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats. Am J Physiol 1983; 245:H1013-H1018
11. Tam SH, Kelly JJ, Williamson PM, Whitworth JA: Reflex sympathetic function in cortisol-induced hypertension in humans. Clin Exp Hypertens 1997; 19: 479-493
12. Dodt C, Keyser B, Mölle M, Fehm HL, Elam M: Acute suppression of muscle sympathetic nerve activity by hydrocortisone in humans. Hypertension 2000; 35: 758-763
13. Scheuer DA, Bechtold AG: Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats. Am J Physiol Regul Integr Comp Physiol 2002; 282:R475-R483
14. Bechtold AG, Scheuer DA: Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1003-R1011
15. Scheuer DA, Mifflin SW: Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 2001; 280:R1440-R1449
16. Mannelli M, Lanzillotti R, Pupilli C, Ianni L, Conti A, Serio M: Adrenal medulla secretion in Cushing's syndrome. J Clin Endocrinol Metab 1994; 78: 1331-1335
17. Lahiri MK, Kannankeril PJ, Goldberger JJ: Assessment of autonomic function in cardiovascular disease: Physiological basis and prognostic implications. J Am Coll Cardiol 2008; 51: 1725-1733
18. Cohen MA, Taylor JA: Phort-term cardiovascular oscillations in man: measuring and modelling the physiologies. J Physiol (Lond) 2002; 542: 669-683
19. Malpas SC: Neural influences on cardiovascular variability: Possibilities and pitfalls. Am J Physiol Heart Circ Physiol 2002; 282:H6-H20
20. Heart rate variability: Ptandards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065
21. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, et al: Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90: 878-883
22. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, et al: Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-2855
23. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-171
24. Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al: The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
25. Lombardi F, Malliani A, Pagani M, Cerutti S: Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996; 32: 208-216
26. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G: Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: The atherosclerosis risk in communities (ARIC) study. Diabetes 2002; 51: 3524-3531
27. Clayton RN: Mortality in Cushing's disease. Neuroendocrinology 2010; 92(suppl 1):71-76
28. Whitworth JA, Mangos GJ, Kelly JJ: Cushing, cortisol, and cardiovascular disease. Hypertension 2000; 36: 912-916
29. Whitworth JA, Williamson PM, Mangos G, Kelly JJ: Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 2005; 1: 291-299
30. Chandran DS, Jaryal AK, Jyotsna VP, Deepak KK: Impaired endothelium mediated vascular reactivity in endogenous Cushing's syndrome. Endocr J 2011; 58: 789-799
31. Scherrer U, Sartori C: Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000; 142: 315-323
32. Chowdhary S, Townend JN: Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci 1999; 97: 5-17